ASCO Lung Cancer Highlights, Part 13: The Immune Checkpoint Inhibitor MPDL3280A in Advanced NSCLC (audio)
- Author
- cancerGRACE - H. Jack West, MD
- Published
- Wed 04 Sep 2013
- Episode Link
- http://cancergrace.libsyn.com/asco-lung-cancer-highlights-part-13-the-immune-checkpoint-inhibitor-mpdl3280a-in-advanced-nsclc-audio
Dr. Edward Garon, David Geffen School of Medicine at UCLA, covers the provocative results of the novel immune checkpoint PD-L1 inhibitor MPDL3280A in advanced NSCLC.
